ALL
51
8
FRT
45
6
NUE
58
7
EFX
36
4
NWS
69
7
SIG
49
6
OKE
81
3
TXT
52
4
O
22
2
EXPE
91
3
ADP
66
2
AVGO
22
2
AXP
69
3
GPC
37
2
KEY
43
3
ZTS
49
2
AIV
70
2
WEC
55
2
DG
4
2
BSX
70
2
ALL
51
8
FRT
45
6
NUE
58
7
EFX
36
4
NWS
69
7
SIG
49
6
OKE
81
3
TXT
52
4
O
22
2
EXPE
91
3
ADP
66
2
AVGO
22
2
AXP
69
3
GPC
37
2
KEY
43
3
ZTS
49
2
AIV
70
2
WEC
55
2
DG
4
2
BSX
70
2
Financhill
Back

WAVE Life Sciences Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44

WVE
WAVE Life Sciences

Last Price:
14.25
Seasonality Move:
-6.6%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

WAVE Life Sciences Price Quote

$14.25
-0.10 (-0.7%)
(Updated: November 22, 2024 at 5:55 PM ET)

WAVE Life Sciences Key Stats

Sell
44
WAVE Life Sciences (WVE) is a Sell
Day range:
$14.08 - $14.52
52-week range:
$3.50 - $16.74
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
33.42
P/B ratio:
15.37%
Volume:
1.3M
Avg. volume:
2M
1-year change:
173.33%
Market cap:
$2.2B
Revenue:
$113.3M
EPS:
$-1.11

How Much Does WAVE Life Sciences Make?

Is WAVE Life Sciences Growing As A Company?

Data Unavailable

WAVE Life Sciences Stock Price Performance

  • Did WAVE Life Sciences Stock Go Up Last Month?
    WAVE Life Sciences share price went down by -5.03% last month
  • Did WVE's Share Price Rise Over The Last Year?
    WVE share price rose by 173.33% over the past 1 year

What Is WAVE Life Sciences 52-Week High & Low?

WAVE Life Sciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy WAVE Life Sciences?

Is WAVE Life Sciences Cash Flow Positive?

  • What Is WVE Cash Flow From Operations?
    Cash flow from operations (TTM) is -$140.6M
  • What Is WAVE Life Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $312.9M
  • What Is WAVE Life Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.2M

WAVE Life Sciences Return On Invested Capital

  • Is Management Doing A Good Job?
    WVE return on invested capital is -437.99%
  • What Is WAVE Life Sciences Return On Assets?
    ROA measures how assets are converting to revenues and is -55.78%
  • What Is WVE Return On Equity?
    ROE is a measure of profitability and is -437.99%

WAVE Life Sciences Earnings Date & Stock Price

WAVE Life Sciences Competitors

  • Who Are WAVE Life Sciences's Competitors?
    Below is a list of companies who compete with WAVE Life Sciences or are related in some way:
    • EUDA Health Holdings Ltd (EUDA)
    • CytoMed Therapeutics Ltd (GDTC)
    • Haw Par Corp Ltd (HAWPF)
    • Mobile-health Network Solutions (MNDR)
    • Raffles Medical Group Ltd (RAFLF)

WAVE Life Sciences Dividend Yield

WAVE Life Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -54.46%
Revenue: 0% -158.78%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 22.30
Upside from Last Price: 55.4%

Major Shareholders

  • How many WVE shares are owned by institutional investors?
    174.1M WVE shares are owned by institutional investors
  • How many WVE shares are owned by insiders?
    6.7M WVE shares are owned by insiders